Clinicians Show High Demand for Single Cell Sequencing, Says Bobby Sebra of Mt. Sinai episode artwork

EPISODE · Oct 5, 2017 · 25 MIN

Clinicians Show High Demand for Single Cell Sequencing, Says Bobby Sebra of Mt. Sinai

from Mendelspod Podcast · host Theral Timpson

If today's guest were a super hero, he'd be High Resolution Sequencing Man.Bobby Sebra is the Director of Technology Development at the Icahn Institute of Genomics and Multiscale Biology at Mt Sinai in New York. He has the complete arsenal of DNA sequencers in his lab. He specializes in long read applications, and today he goes into several of those spaces, including infectious disease and oncology.How has sequencing changed since we last had Bobby on a couple years ago, and how does he see it changing in the next two years? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Episode metadata supplied by the publisher feed · Published Oct 5, 2017

Embed this episode

NOW PLAYING

Clinicians Show High Demand for Single Cell Sequencing, Says Bobby Sebra of Mt. Sinai

0:00 25:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Mendelspod Podcast?

This episode is 25 minutes long.

When was this Mendelspod Podcast episode published?

This episode was published on October 5, 2017.

Can I download this Mendelspod Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!